At the global level, the study reveals that the United States and the United Kingdom remain the dominant producers of ...
Cognizant (Nasdaq: CTSH) today announced a breakthrough from its AI Lab that introduces a novel, efficiency-focused method ...
Speakers at the major conference were all in on agentic AI. But between sessions, some leaders voiced concerns.
A new preliminary study published in Nature suggests that COVID-19 vaccines might actually boost the immune system to make ...
SHELTON, CONNECTICUT / ACCESS Newswire / November 3, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs ...
Responsible AI developer kama.ai signed a strategic partnership with Locadium, a data and AI transformation consultancy specializing in governance, integration, and analytics implementation. The two ...
The dexamethasone insert effectively treats postoperative inflammation and allergic conjunctivitis, with a favorable safety ...
Opinion
7dOpinion
Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit
Science must guide treatment decisions, and healthcare practitioners must take decisive action now to stop inappropriate fibrate prescribing for cardiovascular risk reduction, especially on top of ...
First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, (GLOBE ...
In combination with pembrolizumab, for the first-line treatment of adult patients with advanced renal cell carcinoma (RCC). In combination with everolimus, for the treatment of adult patients with ...
SHELTON, CONNECTICUT / ACCESS Newswire / October 22, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback